Skip to content

Lung Tissue Research Consortium

Lung Tissue Research Consortium

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02988388
Acronym
LTRC
Enrollment
247
Registered
2016-12-09
Start date
2017-02-23
Completion date
2019-02-21
Last updated
2019-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease

Brief summary

The LTRC will facilitate histopathological research of pulmonary diseases by collecting lung tissues from donors and preparing and distributing collections of tissue specimens to researchers within and outside the LTRC. Collections of specimens will be linked to individual clinical data appropriate to the particular disease. The primary goal of the LTRC is to identify participants with suspected lung cancer or metastatic disease who are willing to provide informed consent for research use of their specimens and data. Secondarily, the LTRC investigators intend to collect clinical data, limited exposure data, physiologic studies, and radiographic studies from these participants.

Interventions

PROCEDURELung biopsy/lobectomy

Lung biopsies and lobectomies are not experimental. Participants will undergo a lung biopsy or a lobectomy as part of standard of care.

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)
Lead SponsorNIH

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adults ages 21 or older who are undergoing lung surgery for suspected malignancy or metastases.

Exclusion criteria

* Diagnosis of cystic fibrosis or pulmonary hypertension. * Any other condition that, in the judgment of the investigator, precludes participation. * Failure to obtain written consent.

Design outcomes

Primary

MeasureTime frameDescription
Clinical diagnosisTwo months following surgeryA final diagnosis of the participant's lung disease will be rendered by the clinical center PI.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026